Literature DB >> 5426662

5-hydroxyindoleacetic acid in the brain and cerebrospinal fluid of the rabbit following administration of drugs affecting 5-hydroxytryptamine.

M B Bowers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5426662     DOI： 10.1111/j.1471-4159.1970.tb03357.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN： 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  5 in total

1.  Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors.

Authors:  P Hartikainen; H Soininen; K J Reinikainen; J Sirviö; R Soikkeli; P J Riekkinen
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  Variations in the 5-hydroxy-indoleacetic acid concentration in the cerebrospinal fluid during the sleep-wake cycle in man.

Authors:  R Raffaele; A Reggio; R Tropea; G Pennisi; A Falsaperla; F Nicoletti
Journal:  Ital J Neurol Sci       Date:  1983-04

3.  Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone.

Authors:  N A Garrick; T Seppala; M Linnoila; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Cerebrospinal fluid 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in unipolar depressives treated with amitriptyline.

Authors:  M B Bowers
Journal:  Psychopharmacologia       Date:  1972

5.  The effects of probenecid on cyclic adenosine 3',5'-monophosphate levels in cerebrospinal fluid and on brain phosphodiesterase activity in the rat.

Authors:  R Horstmann; R Hammers; P Clarenbach; H Cramer
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1983
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.